Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: 200302385, 2003; 10.1373/clinchem.2003.023853
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2003.023853v1
50/2/346    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Averina, M.
Right arrow Articles by Kalinin, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Averina, M.
Right arrow Articles by Kalinin, A. G.

Received on July 1, 2003
Accepted on November 25, 2003

Lipids, Lipoproteins, and Cardiovascular Risk Factors

Factors behind the Increase in Cardiovascular Mortality in Russia: Apolipoprotein AI and B Distribution in the Arkhangelsk Study 2000

Maria Averina 1*, Odd Nilssen 2, Tormod Brenn 2, Jan Brox 3, Vadim L. Arkhipovsky 4, Alexei G. Kalinin 5

1 Institute of Community Medicine, Medical Faculty, University of Tromsø, N-9037 Tromsø, Norway and
2 Institute of Community Medicine, Medical Faculty, University of Tromsø, N-9037 Tromsø, Norway
3 Department of Clinical Chemistry, University Hospital of Tromsø, Tromsø, Norway
4 Semashko Clinic, Arkhangelsk, Russia
5 Northern State Medical University, Arkhangelsk, Russia

* To whom correspondence should be addressed. E-mail: Maria.Averina{at}ism.uit.no.

Background: Cardiovascular mortality is remarkably higher in Russia than in Western Europe and the US. Little is known about indicators of atherosclerotic risk in the Russian population. To our knowledge, this is the first study of apolipoprotein (apo) AI and B in Russia based on the WHO-IFCC standard.

Methods: We measured apo AI and B by immunoturbidimetric assay in 3694 men and women from Arkhangelsk, Russia, in 1999-2000.

Results: The age-related distribution of apo B was similar to that in other countries, whereas the apo AI profile was different. For men >=20 years, apo AI was considerable higher than in studies from other countries. Women had also relatively high apo AI concentrations, although the difference was not as pronounced as in men. The apo AI concentration was positively associated with age and lifestyle variables such as alcohol consumption and physical activity, and negatively associated with body mass index and self-reported myocardial infarction. {gamma}-Glutamyltransferase was positively associated with apo AI in both sexes.

Conclusions: The apparently favorable apolipoprotein profiles contrast with official death statistics indicating high cardiovascular mortality in Russia. High apo AI might indicate excessive alcohol consumption.




The following articles in journals at HighWire Press have cited this article:


Home page
J Am Coll CardiolHome page
E. M. deGoma, N. J. Leeper, and P. A. Heidenreich
Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.
J. Am. Coll. Cardiol., January 1, 2008; 51(1): 49 - 55.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. H. O'Keefe, K. A. Bybee, and C. J. Lavie
Alcohol and Cardiovascular Health: The Razor-Sharp Double-Edged Sword
J. Am. Coll. Cardiol., September 11, 2007; 50(11): 1009 - 1014.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
O. Nilssen, M. Averina, T. Brenn, J. Brox, A. Kalinin, and V. Archipovski
Alcohol consumption and its relation to risk factors for cardiovascular disease in the north-west of Russia: the Arkhangelsk study
Int. J. Epidemiol., August 1, 2005; 34(4): 781 - 788.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2003 by the American Association for Clinical Chemistry.